Compare Abeona Therapeutics Inc (ABEO) vs Ferrari NV (RACE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Abeona Therapeutics Inc vs Ferrari NV — how do they compare? Abeona Therapeutics Inc trades at $7.57 (market cap $421.19M), while Ferrari NV trades at $409.2 (market cap $71.67B). The key difference: Ferrari NV is far larger — about 170.2× Abeona Therapeutics Inc's market cap, and Ferrari NV pays a 1.04% dividend while Abeona Therapeutics Inc pays none. Which is the better fit depends on your goals.
| ABEO | RACE | |
|---|---|---|
Market Cap | $421.19M | $71.67B |
Sector | Health | Consumer Cyclical |
52-Week High | $7.45 | $504.09 |
52-Week Low | $4.17 | $314.63 |
Enterprise Value | $276.10M | $73.60B |
Dividend Yield | — | 1.04% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About Ferrari NV
Ferrari engineers and manufactures some of the world's most expensive exotic sports cars. The Ferrari brand is synonymous with Formula One racing, exclusivity, Italian design, and state-of-the-art technology. Ferrari also has a captive finance company that provides funding for dealers and clients.
Read more on RACE →
